Entropy Technologies LP Purchases Shares of 54,313 Colgate-Palmolive (NYSE:CL)

Entropy Technologies LP purchased a new position in Colgate-Palmolive (NYSE:CL - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 54,313 shares of the company's stock, valued at approximately $5,638,000. Colgate-Palmolive accounts for approximately 0.6% of Entropy Technologies LP's investment portfolio, making the stock its 26th largest position.

A number of other institutional investors also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at about $25,000. Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the third quarter worth about $53,000. Finally, Gradient Investments LLC lifted its position in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded down $0.45 during mid-day trading on Tuesday, hitting $91.51. The company had a trading volume of 4,927,123 shares, compared to its average volume of 4,377,176. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $75.17 and a 1 year high of $109.30. The company has a market capitalization of $74.76 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 3.31 and a beta of 0.42. The stock's 50-day moving average price is $100.62 and its 200-day moving average price is $98.52.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company's stock.

Analysts Set New Price Targets

CL has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Sanford C. Bernstein boosted their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a "market perform" rating in a research note on Tuesday, July 30th. HSBC reiterated a "hold" rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research note on Monday, October 28th. Finally, Jefferies Financial Group lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their target price for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.